Trial Archives - tgiHealthCareerp

Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH

04/18/2019 2, Albireo, Announces, Clearance, Commence, Elobixibat, FDA, for, IND, NAFLD/NASH, of, Phase, The, to, Treatment, Trial

BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing

Read more

Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata

01/05/2019 2b/3, Alopecia, an, Areata, Clinical, for, Inhibitor, Initiates, JAK3, Moderate, of, Oral, Patients, PF-06651600, Pfizer, Phase, Severe, The, to, Treatment, Trial, with

January 3, 2019 — Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its

Read more